USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:37 PM 2012

NYSE 8092.67 9.69 Index Moved Up

NASDAQ 2929.83 13.97 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and DDSS...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Labopharm Inc.

Volatility

Matrix

Run Correlation

Diversification

Pay attention

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Labopharm Inc. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.0

Parameters

Time Period	1 Month [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Suggest

48.91

Intraday

One Month

^(0.31)

0.63%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	149720
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.63%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.31
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable